OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression
Xin Yan, Zefeng Xu, Peihong Zhang, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Xin Yan, Zefeng Xu, Peihong Zhang, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Showing 6 citing articles:
Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements
Tanvi Verma, Nikolaos Papadantonakis, Deniz Peker Barclift, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 514-514
Open Access | Times Cited: 6
Tanvi Verma, Nikolaos Papadantonakis, Deniz Peker Barclift, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 514-514
Open Access | Times Cited: 6
Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments
Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose
Cancers (2023) Vol. 15, Iss. 13, pp. 3331-3331
Open Access | Times Cited: 14
Helen T. Chifotides, Srđan Verstovšek, Prithviraj Bose
Cancers (2023) Vol. 15, Iss. 13, pp. 3331-3331
Open Access | Times Cited: 14
Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjects
Jun Dai, Cheng Yang, Yannan Zhou, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Jun Dai, Cheng Yang, Yannan Zhou, et al.
Cancer Chemotherapy and Pharmacology (2025) Vol. 95, Iss. 1
Closed Access
Disease progression in patients with low-risk primary myelofibrosis: Case report
Mihailo Smiljanić, Isidora Arsenović, Andrija Bogdanović, et al.
Srpski medicinski casopis Lekarske komore (2024) Vol. 5, Iss. 3, pp. 459-467
Open Access
Mihailo Smiljanić, Isidora Arsenović, Andrija Bogdanović, et al.
Srpski medicinski casopis Lekarske komore (2024) Vol. 5, Iss. 3, pp. 459-467
Open Access
Spatial-transcriptomic profiling: a new lens for understanding myelofibrosis pathophysiology
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Edoardo Peroni, Elisabetta Calistri, Rosario Amato, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Letter by Lucijanic and Krecak Regarding Article, “Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation”
Marko Lucijanić, Ivan Krečak
Circulation (2024) Vol. 150, Iss. 21
Closed Access
Marko Lucijanić, Ivan Krečak
Circulation (2024) Vol. 150, Iss. 21
Closed Access
